Consumer Staples > Tobacco & Cannabis
•52 stocks
•
Total Market Cap: Loading...
Market Cap Distribution
Price Performance Heatmap
5Y Price (Market Cap Weighted)
All Stocks (52)
%
| Company | Market Cap | Price |
|---|---|---|
|
PMI directly manufactures and sells traditional tobacco products (cigarettes and related smokable goods), which remain a core revenue stream even as the company pivots to smoke-free products.
|
$249.77B |
$160.47
+1.97%
|
|
BAT directly manufactures and sells tobacco products including cigarettes, cigars, smokeless tobacco, and vaping products.
|
$113.57B |
$52.11
|
|
Direct tobacco product category including cigarettes and smokeless tobacco, which MO primarily manufactures and sells (Marlboro and on!).
|
$112.08B |
$66.54
+0.67%
|
|
The mix of tobacco products and nicotine alternatives remains part of Casey’s offering despite shifts toward higher-margin alternatives.
|
$20.70B |
$556.67
+0.73%
|
|
Tobacco products are part of the Convenience segment’s mix, reflecting distribution of tobacco products.
|
$15.60B |
$99.95
-0.43%
|
|
Nicotine/tobacco products are a core non-fuel merchandise category in the store network.
|
$7.67B |
$388.26
-0.63%
|
|
Directly produces e-cigarettes, vaping devices and related hardware/cartridge systems as core product lines.
|
$3.77B |
$2.40
+0.42%
|
|
Tilray is a leading Canadian cannabis operator with recreational cannabis revenue and market leadership, matching Cannabis - Recreational.
|
$1.89B |
$1.72
-14.43%
|
|
TPB directly sells tobacco products (Stoker's MST) and related nicotine products under its Stoker's/MST brands.
|
$1.75B |
$98.03
-0.53%
|
|
Cannabis - Recreational products and adult-use cannabis operations form GTBIF's core product line and revenue driver.
|
$1.60B |
$7.27
-7.51%
|
|
ZYN002 uses synthetic cannabidiol delivered as a transdermal gel, representing cannabis-based medical therapeutics in development.
|
$1.52B |
$26.54
-1.19%
|
|
Directly produces and sells cannabis for recreational use, aligning with Trulieve's multi-state recreational cannabis operations.
|
$1.46B |
$7.64
+5.67%
|
|
Directly produces and supplies leaf tobacco as its core Tobacco Operations (leaf procurement, processing, blending, testing, and just-in-time delivery).
|
$1.35B |
$53.59
-1.34%
|
|
Direct cannabis product line for recreation (flower, edibles, vapes) under Spinach and related brands.
|
$1.01B |
$2.63
-0.75%
|
|
SNDL's core cannabis business in Canada, including the Indiva infusion-edibles portfolio, is the primary revenue and growth driver and is explicitly categorized as Cannabis - Recreational.
|
$666.00M |
$2.52
-10.95%
|
|
Backbar refresh and OTP focus indicate tobacco product sales at stores.
|
$523.05M |
$4.59
-0.86%
|
|
Village Farms directly produces and sells recreational cannabis in Canada (Pure Sunfarms) and in the Netherlands (Leli Holland).
|
$371.84M |
$3.31
-9.81%
|
|
Aurora's core business is global medical cannabis cultivation, processing, and distribution, making Cannabis - Medical its primary direct product tag.
|
$290.85M |
$5.30
-12.11%
|
|
High Tide operates recreational cannabis retail stores and sells cannabis products in Canada.
|
$275.93M |
$3.43
-5.51%
|
|
Direct production and sale of recreational cannabis products (adult-use) in Canada and related markets.
|
$253.71M |
$1.37
-13.84%
|
|
Ranco co-packing and hemp-based product manufacturing/license (Packwoods) directly implies hemp-derived CBD product production.
|
$238.57M |
$2.01
|
|
Directly produces cannabis for recreational use and related products (vapes, edibles, pre-rolls, beverages) in Canada and internationally.
|
$198.26M |
$1.91
-4.50%
|
|
Direct involvement in producing and selling recreational cannabis products through cultivation, manufacturing, and retail/distribution.
|
$180.71M |
$0.88
-0.68%
|
|
BLMH sells cannabis products for adult-use (recreational) in California through its dispensaries and Korova brand, constituting a direct product line.
|
$162.23M |
$0.70
|
|
Direct product category: e-cigarettes and vaping devices sold/manufactured by the company.
|
$125.72M |
$2.20
-7.95%
|
|
Direct cannabis product category: recreational cannabis produced and sold by Jushi in multiple states.
|
$120.18M |
$0.61
+0.05%
|
|
Directly produces and sells hemp-derived THC beverages under the Señorita brand.
|
$91.73M |
$41.14
-2.02%
|
|
Core business is leaf tobacco procurement, processing, and shipping to manufacturers, i.e., direct tobacco product supply.
|
$81.21M |
$3.30
|
|
Directly produces and sells recreational cannabis products through its Nevada retail operations (dispensaries) and product portfolio.
|
$80.81M |
$0.40
-4.76%
|
|
Planet 13 operates cannabis dispensaries and sells recreational cannabis products, notably via its Las Vegas SuperStore and other retail channels.
|
$77.76M |
$0.22
-6.14%
|
|
Direct medical cannabis product line and physician-dispensed therapies.
|
$72.92M |
$1.60
-4.76%
|
|
Significant revenue and distribution of tobacco products (cigarettes and related items) in the wholesale segment.
|
$72.56M |
$112.42
|
|
Company's direct products include Metatine-based SBX disposables and Pachamama/Pacha Disposable e-cigarette/lÃquids, i.e., vaping devices and liquids in the E-cigarettes & Vaping category.
|
$72.13M |
$0.32
-2.73%
|
|
Directly produces and sells recreational cannabis products under established brand lines across multiple states.
|
$53.25M |
$0.17
-2.88%
|
|
HCMC's core focus on vape technology and related devices (Q-Cup) aligns with the E-cigarettes & Vaping category.
|
$48.13M |
$0.00
|
|
Cannabinoid-based therapies derived from hemp/CBD fit Hemp & CBD products.
|
$33.48M |
$0.40
-4.29%
|
|
Day Three Labs cannabis technology aligns with Cannabis - Medical.
|
$33.38M |
$1.34
-1.47%
|
|
MIRA-55 is described as a CB2-selective oral cannabinoid molecule, aligning with Cannabis - Medical category.
|
$21.32M |
$1.26
-6.67%
|
|
IHL-42X uses dronabinol (cannabinoid) in its formulation, a cannabis-based medical therapy.
|
$11.53M |
$0.39
-9.33%
|
|
cbdMD's core product lineup is hemp-derived CBD products (Hemp & CBD).
|
$10.96M |
$1.23
-13.99%
|
|
Direct hemp-derived CBD products under PlusCBD brand; core product category.
|
$7.37M |
$0.04
+1.15%
|
|
Pivot centers on premium skincare/wellness products with hemp/CBD elements, i.e., Hemp & CBD products.
|
$7.09M |
$0.06
-7.69%
|
|
Directly produces and sells ENDS/vaping devices (Bidi Stick), the company's legacy core product.
|
$6.58M |
$0.57
-6.56%
|
|
Mary Jones HD9 is hemp-derived (Delta-9) beverage product, aligning with Hemp & CBD offerings.
|
$6.17M |
$0.16
-11.06%
|
|
BUDZ maintains an inventory of high THC strains and CBD/CBG strains via Hemp empirical Genetics, aligning with Hemp & CBD product categories.
|
$5.44M |
$0.04
-10.02%
|
|
Cannabis - Recreational: portfolio anchored in regulated cannabis real estate for retailers.
|
$5.37M |
$0.45
+1.36%
|
|
Sells vaping devices and e-cigarette accessories, including CCELL, placing it in the E-cigarettes & Vaping category.
|
$5.27M |
$3.87
-4.91%
|
|
Core product offering is medical cannabis products produced and distributed for medical use.
|
$4.31M |
$1.93
-4.46%
|
|
Core business is the Star Buds cannabis retail network in Canada, i.e., recreational cannabis sales.
|
$3.29M |
$0.03
|
|
OWPC's pivot centers on hemp-derived CBD products (Pro-11) and hemp-based materials, directly aligning with Hemp & CBD product category.
|
$2.83M |
$0.02
-24.71%
|
|
Cannabis - Recreational: CBDY operates a licensed Canadian producer with cultivation, processing, and sales for recreational cannabis.
|
$1.05M |
$0.00
|
|
Hemp-derived CBD products via the Gabriola Island facility (hemp license).
|
$905027 |
$2.18
-5.22%
|
Loading industry metrics...
Loading comparison data...
